APP下载

产超广谱β—内酰胺酶细菌致社区感染与医院感染耐药性调查分析

2018-12-18史瑀穆金智殷翠香

中国现代医生 2018年23期

史瑀 穆金智 殷翠香

[摘要] 目的 探討产超广谱β-内酰胺酶细菌致社区感染与医院感染耐药性分析,为指导临床合理用药提供依据。方法 收集2014年1月~2017年12月检验科细菌培养产ESBLs的大肠埃希菌、肺炎克雷伯菌、奇异变形菌以及产酸克雷伯菌的菌株,在剔除重复菌株后,进行细菌耐药谱调查,并判断是否为医院感染,同时分析社区感染与医院感染的耐药性差异。 结果 我院2014年1月~2017年12月共检出产ESBLs细菌共647例,社区感染598例,医院感染49例,在对我院社区感染与医院感染的产ESBLs大肠埃希菌耐药率的比较中,发现医院感染的产ESBLs大肠埃希菌对米诺环素、庆大霉素、丁胺卡那霉素、头孢哌酮、头孢西丁以及头孢他啶的耐药性要高于社区感染;医院感染的产ESBLs肺炎克雷伯菌对米诺环素、头孢哌酮、头孢西丁及头孢曲松的耐药性要高于社区感染,并且以上差异均具有统计学意义(P<0.05)。 结论 院感工作人员应了解医院感染与社区感染的耐药性差异,并将结果及时反馈给临床科室,为临床合理使用抗菌药物提供准确的参考。

[关键词] 产超广谱β-内酰胺酶;社区感染;医院感染;耐药性

[中图分类号] R378.9 [文献标识码] B [文章编号] 1673-9701(2018)23-0149-04

Investigation and analysis on drug resistance to community infection and nosocomial infection caused by extended-spectrum β-lactamase producing bacteria

SHI Yu MU Jinzhi YIN Cuixiang ZHAO Jian LI Zewen

Department of Infection Monitoring, No.2 School of Clinical Medicine, Inner Mongolia University For Nationalities, Inner Mongolia Forestry General Hospital, Yakesh 022150, China

[Abstract] Objective To investigate the drug resistance of extended-spectrum β-lactamase producing bacteria in community infection and nosocomial infection, and to provide guidance for clinical rational drug use. Methods The strains of ESBLs-producing Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Klebsiella oxysporum were collected from the bacterial cultures of the Clinical Laboratory from January 2014 to December 2017. After eliminating duplicate strains, an investigation of bacterial resistance patterns was conducted, and whether it was nosocomial infection was determined. At the same time, the differences in drug resistance between community infections and nosocomial infections were analyzed. Results A total of 647 ESBLs-producing bacteria were detected in our hospital from January 2014 to December 2017. There were 598 cases of community infection and 49 cases of nosocomial infections. In the comparison of drug resistance rates of ESBLs-producing Escherichia coli in community infection and nosocomial infection in our hospital, it was found that ESBLs-producing E. coli in nosocomial infection were more resistant to minocycline, gentamycin, amikacin, cefoperazone, cefoxitin and ceftazidime than that in community infection; the ESBLs-producing Klebsiella pneumoniae in nosocomial infection was more resistant to minocycline, cefoperazone, cefoxitin, and ceftriaxone than that in community infection. The above differences were statistically significant(P<0.05). Conclusion The staff in nosocomial infection department should understand the difference in drug resistance between nosocomial infection and community infection. The results should be sent back to the clinical departments in a timely manner, so as to provide an accurate reference for the rational use of antimicrobial drugs in clinical practice.

[Key words] Extended-spectrum β-lactamase producing bacteria; Community infection; Hospital infection; Drug resistance

产超广谱β-内酰胺酶(ESBLs)主要是一种由质粒介导的可以水解广谱β-内酰胺抗生素的一种酶,主要产生于肠杆菌科细菌,如大肠埃希菌和肺炎克雷伯菌,另外在奇异变形菌与产酸克雷伯菌重也可产生但数量较少[1,2]。由于ESBLs可以在同种甚至异种细菌间逐代传播,并且可以引起医院感染的流行,因此必须加强对产ESBLs细菌耐药性的监测[3]。本研究收集内蒙古林业总医院产ESBLs细菌,并对其进行社区感染与医院感染的诊断,并分析社区感染与医院感染耐药谱的差别,为医院感染监测提供相关预警资料,同时对抗菌药物的使用提供数据支持。……

登录APP查看全文